AMLODIPINE/VALSARTAN NOVARTIS 5/80 amlodipine 5 mg/valsartan 80 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

amlodipine/valsartan novartis 5/80 amlodipine 5 mg/valsartan 80 mg film-coated tablet blister pack

novartis pharmaceuticals australia pty ltd - amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg); valsartan, quantity: 80 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; crospovidone; colloidal anhydrous silica; titanium dioxide; hypromellose; purified talc; macrogol 4000; iron oxide yellow - amlodipine/valsartan novartis is indicated for the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

APO-Valsartan HCTZ 80/12.5 valsartan 80 mg and hydrochlorothiazide 12.5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-valsartan hctz 80/12.5 valsartan 80 mg and hydrochlorothiazide 12.5 mg tablet blister pack

apotex pty ltd - hydrochlorothiazide,valsartan -

APO-Valsartan HCTZ 160/25 valsartan 160 mg and hydrochlorothiazide 25 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-valsartan hctz 160/25 valsartan 160 mg and hydrochlorothiazide 25 mg tablet blister pack

apotex pty ltd - hydrochlorothiazide,valsartan -

APO-Valsartan HCTZ 160/12.5 valsartan and hydrochlorothiazide 160/12.5 mg tablet blisters Australia - English - Department of Health (Therapeutic Goods Administration)

apo-valsartan hctz 160/12.5 valsartan and hydrochlorothiazide 160/12.5 mg tablet blisters

apotex pty ltd - hydrochlorothiazide,valsartan -

APO-Valsartan HCTZ 320/25 valsartan and hydrochlorothiazide 320/25 mg tablet blisters Australia - English - Department of Health (Therapeutic Goods Administration)

apo-valsartan hctz 320/25 valsartan and hydrochlorothiazide 320/25 mg tablet blisters

apotex pty ltd - hydrochlorothiazide,valsartan -

APO-Valsartan HCTZ 320/12.5 valsartan and hydrochlorothiazide 320/12.5 mg tablet blisters Australia - English - Department of Health (Therapeutic Goods Administration)

apo-valsartan hctz 320/12.5 valsartan and hydrochlorothiazide 320/12.5 mg tablet blisters

apotex pty ltd - hydrochlorothiazide,valsartan -

AMLODIPINE/VALSARTAN/HCT NOVARTIS 5/160/25 amlodipine/valsartan/hydrochlorothiazide tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

amlodipine/valsartan/hct novartis 5/160/25 amlodipine/valsartan/hydrochlorothiazide tablet blister pack

novartis pharmaceuticals australia pty ltd - hydrochlorothiazide, quantity: 25 mg; valsartan, quantity: 160 mg; amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg) - tablet, film coated - excipient ingredients: colloidal anhydrous silica; microcrystalline cellulose; crospovidone; magnesium stearate; titanium dioxide; hypromellose; purified talc; macrogol 4000; iron oxide yellow - amlodipine/valsartan/hct novartis is indicated only as substitution therapy for the treatment of hypertension in patients whose blood pressure is already adequately controlled on the triple combination of amlodipine, valsartan and hydrochlorothiazide taken either as three single component formulations or as dual-component formulation with a single component formulation, all components at the same dose level. treatment should not be initiated with these fixed-dose combinations (see dosage and administration).

AMLODIPINE/VALSARTAN NOVARTIS 5/160 amlodipine 5 mg/valsartan 160 mg film-coated tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

amlodipine/valsartan novartis 5/160 amlodipine 5 mg/valsartan 160 mg film-coated tablets blister pack

novartis pharmaceuticals australia pty ltd - valsartan, quantity: 160 mg; amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; crospovidone; magnesium stearate; colloidal anhydrous silica; hypromellose; purified talc; iron oxide yellow; macrogol 4000; titanium dioxide - amlodipine/valsartan novartis is indicated for the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

AMLODIPINE/VALSARTAN/HCT NOVARTIS 10/320/25 amlodipine/valsartan/hydrochlorothiazide tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

amlodipine/valsartan/hct novartis 10/320/25 amlodipine/valsartan/hydrochlorothiazide tablet blister pack

novartis pharmaceuticals australia pty ltd - valsartan, quantity: 320 mg; hydrochlorothiazide, quantity: 25 mg; amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg) - tablet, film coated - excipient ingredients: magnesium stearate; colloidal anhydrous silica; crospovidone; microcrystalline cellulose; hypromellose; purified talc; iron oxide yellow; macrogol 4000 - amlodipine/valsartan/hct novartis is indicated only as substitution therapy for the treatment of hypertension in patients whose blood pressure is already adequately controlled on the triple combination of amlodipine, valsartan and hydrochlorothiazide taken either as three single component formulations or as dual-component formulation with a single component formulation, all components at the same dose level. treatment should not be initiated with these fixed-dose combinations (see dosage and administration).

AMLODIPINE/VALSARTAN/HCT NOVARTIS 10/160/12.5 amlodipine/valsartan/hydrochlorothiazide tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

amlodipine/valsartan/hct novartis 10/160/12.5 amlodipine/valsartan/hydrochlorothiazide tablet blister pack

novartis pharmaceuticals australia pty ltd - valsartan, quantity: 160 mg; amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg); hydrochlorothiazide, quantity: 12.5 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; colloidal anhydrous silica; crospovidone; magnesium stearate; hypromellose; purified talc; iron oxide red; macrogol 4000; iron oxide yellow; titanium dioxide - amlodipine/valsartan/hct novartis is indicated only as substitution therapy for the treatment of hypertension in patients whose blood pressure is already adequately controlled on the triple combination of amlodipine, valsartan and hydrochlorothiazide taken either as three single component formulations or as dual-component formulation with a single component formulation, all components at the same dose level. treatment should not be initiated with these fixed-dose combinations (see dosage and administration).